輸入代號或公司名稱後按 Enter
4106

雃博

-0.05 (-0.20%)最後更新 2026-09-11
台灣 · 上市 · 生技醫療業
24.35115成交張數13.23本益比0.97股價淨值比4.11%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q20.63186.4%1.840.649.5%2.55%7.63%
2026Q10.46100.0%1.430.468.0%1.85%5.88%
2025Q40.28-39.1%1.200.294.6%1.15%4.90%
2025Q30.47571.4%1.380.477.5%1.95%5.72%
2025Q20.224.8%0.980.233.8%0.95%4.24%
2025Q10.23-42.5%0.970.234.2%0.95%4.13%
2024Q40.4670.4%1.140.467.5%1.91%4.85%
2024Q30.07-69.6%0.950.081.4%0.33%4.05%
2024Q20.21-58.8%1.110.213.6%0.90%4.81%
2024Q10.40-20.0%1.410.406.2%1.71%6.13%
2023Q40.2742.1%1.510.273.9%1.14%6.68%
2023Q30.23-61.0%1.430.244.2%1.04%6.50%
2023Q20.51-1.9%1.790.517.2%2.23%8.30%
2023Q10.5066.7%1.800.517.2%2.25%8.23%
2022Q40.19171.4%1.600.192.8%0.89%7.54%
2022Q30.5990.3%1.480.608.6%2.84%7.10%
2022Q20.5252.9%1.200.527.6%2.46%5.76%
2022Q10.303.5%1.020.315.1%1.47%4.90%
2021Q40.07-50.0%1.010.081.2%0.37%4.91%
2021Q30.3110.7%1.080.315.2%1.47%5.25%
2021Q20.34-38.2%1.050.356.0%1.63%5.11%
2021Q10.29314.3%1.260.295.0%1.38%6.12%
2020Q40.14-26.3%1.040.142.5%0.67%5.07%
2020Q30.28133.3%1.090.285.3%1.37%5.41%
2020Q20.55189.5%0.930.5510.9%2.75%4.69%
2020Q10.07-81.1%0.570.071.8%0.37%2.85%
2019Q40.19-47.2%0.870.193.7%0.96%4.35%
2019Q30.12-62.5%1.040.132.6%0.62%5.76%
2019Q20.19-32.1%1.240.193.6%0.92%6.51%
2019Q10.3732.1%1.330.377.2%1.82%6.60%
2018Q40.3650.0%1.240.356.2%1.95%5.98%
2018Q30.3214.3%1.120.265.3%1.64%5.81%
2018Q20.28-51.7%1.080.244.4%1.48%5.73%
2018Q10.28-12.5%1.380.234.6%1.42%7.25%
2017Q40.2426.3%1.420.203.9%1.25%7.48%
2017Q30.28-12.5%1.370.234.1%1.47%7.26%
2017Q20.5845.0%1.410.499.0%3.16%7.50%
2017Q10.32-42.9%1.230.265.6%1.71%6.34%
2016Q40.191.470.163.0%1.02%
2016Q30.320.266.1%1.68%